Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Peptides Application After Non-surgical Periodontal Therapy
NCT05530252Phase 4Completed
- Sponsor
- Beijing Stomatological Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of Biokiller in periodontitis (3 arms), sponsored by Beijing Stomatological Hospital. Primary endpoints: Periodontal Probing Depth at 90 days, Attachment Level at 90 days and 1 more. Started Sep 2022; status: completed.
02
Drugs
Biokiller
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05530252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05530252.